Sunvepra (asunaprevir) will soon be considered for BC PharmaCare coverage. Therefore, your input will again soon be sought.
Tentatively, patient and caregiver input into Sunvepra’s approval process will be requested from Wednesday May 18, 2016 to MIDNIGHT ON Wednesday June 15, 2016.
How to Add Your Voice to the BC PharmaCare Coverage Review for Sunvepra (asunaprevir)
If you are a BC resident and answer yes to any of the following questions, you can give your input into whether or not the treatment should be covered by BC PharmaCare:
- Do you have hep C?
- Are you a caregiver/loved one to someone who has hep C?
- Does your patient group represent patients who have hep C AND have you registered with PharmaCare to give input? (Learn more about registering your organization).
Please note that PharmaCare’s questionnaire for Sunvepra (asunaprevir) input tentatively wont be available for another two weeks. The Hepatitis C Treatment Information Project will follow this development and keep you updated.
Sunvepra (asunaprevir) is prescribed in combination with other treatments/direct-acting antivirals (DAAs) for patients with chronic hepatitis C genotypes 1 or 4 and compensated liver disease, including cirrhosis.
Sunvepra in combination with Daklinza, peginterferon, and ribavirin, was tested on those with hep C genotype 1 or 4 who were prior non-responders (patients who tried treatment but it failed to achieve SVR/’cure’) and succeeded with great results. High SVR12 rates were achieved with genotype 1 (93.2%) and genotype 4 (100%) patients. (Health Canada)
*Health Canada granted Sunvepra a Notice of Compliance (NOC) on March 9th, 2016. A CADTH Common Drug Review for Sunvepra began in 2015 and patient input was sent in by Canadian patient groups, including the Pacific Hepatitis C Network, for this review then. After the input was sent, the CADTH Common Drug Review was temporarily suspended as the manufacturer, Bristol Myers Squibb Canada Inc., requested time to provide additional information. This temporary suspension was lifted on March 15th, 2016.